Taysha Gene Therapies, Inc. (TSHA) Q2 2022 Earnings Call Transcript
Joining me on today's call are RA Session II Taysha's president, founder, and CEO; Dr. Frederick Porter, chief technical officer; Dr. Suyash Prasad, chief medical officer and head of R&D and Kamran Alam, chief financial officer. After our formal remarks, we will conduct a question-and-answer session and instructions will follow at that time.